Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | AMGN | VRTX | REGN | BMY |
| Company | Urogen Pharma Ltd | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 14.06 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 14.54 | 277.25 | 402.48 | 901.44 | 44.47 |
| Low | 13.89 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 14.17 | 275.57 | 400.23 | 901.04 | 43.97 |
| Change | +0.35 | +1.63 | +7.42 | +10.38 | +0.03 |
| % Change | +2.53% | +0.60% | +1.89% | +1.17% | +0.07% |
| Volume | 77,627 | 886,580 | 501,485 | 201,162 | 7,186,701 |
| 20-Day Average Volume | 296,310 | 2,168,536 | 960,345 | 456,430 | 13,740,970 |
| Previous Close | 13.82 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.00 | 269.61 | 398.77 | 908.85 | 48.21 |
| 20-Day Raw Stochastic | 54.95% | 91.04% | 39.34% | 26.14% | 4.63% |
| 20-Day Relative Strength | 45.79% | 51.34% | 45.67% | 40.32% | 28.11% |
| Weighted Alpha | -36.31 | +13.64 | +13.74 | +16.17 | -36.42 |
| Today's Opinion | 40% Sell | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Previous Opinion | 40% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 8% Sell | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.84% since 04/24/24 | +1.01% since 04/24/24 | -0.31% since 04/24/24 | -0.95% since 04/24/24 | -9.71% since 04/24/24 |
| Low | 13.69 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 14.68 on 04/29/24 | 277.24 on 05/01/24 | 403.88 on 04/25/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | -0.77% since 04/01/24 | -2.57% since 04/01/24 | -4.98% since 04/01/24 | -7.36% since 04/01/24 | -16.75% since 04/01/24 |
| Low | 12.37 on 04/11/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 15.50 on 04/15/24 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | -11.38% since 02/01/24 | -15.04% since 02/01/24 | -7.92% since 02/01/24 | -6.25% since 02/01/24 | -9.36% since 02/01/24 |
| Low | 12.37 on 04/11/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 19.87 on 02/16/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +24.03% since 11/01/23 | +5.72% since 11/01/23 | +8.17% since 11/01/23 | +13.48% since 11/01/23 | -13.97% since 11/01/23 |
| Low | 10.92 on 11/15/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 19.87 on 02/16/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 324,134 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 23,454 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 82,710,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -102,240,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 23,530,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -26,020,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.07 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 03/14/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |